XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Scientists uncover how BRCA2 regulates DNA repair
Apr 10, 2005, 02:19, Reviewed by: Dr.

They found that a 'molecular switch' on the BRCA2 protein controls interactions between BRCA2 and RAD51, which are necessary for normal levels of repair. The new work shows that mutations in the BRCA2 protein affect this switch, and this can have severe effects on the efficiency of DNA repair and in some cases lead to cancer. Women with a faulty BRCA2 gene lack the ability to repair damaged DNA by this repair process.

 
Cancer Research UK scientists have discovered a 'molecular switch' that controls an essential DNA repair process, a study published in Nature* reveals.

Women who carry a faulty BRCA2 gene are more likely to develop breast and ovarian cancer. The reason for this is linked to defects in a process which repairs DNA breaks.

During normal cell growth it is common for breaks to occur in the DNA, and the cell has specialised repair processes that repair these breaks. One such repair process is dependent on a protein called RAD51.

Researchers from Cancer Research UK's London Research Institute took a closer look at the relationship between RAD51 and BRCA2 protein, which is the product of the normal BRCA2 gene.

They found that a 'molecular switch' on the BRCA2 protein controls interactions between BRCA2 and RAD51, which are necessary for normal levels of repair.

The new work shows that mutations in the BRCA2 protein affect this switch, and this can have severe effects on the efficiency of DNA repair and in some cases lead to cancer. Women with a faulty BRCA2 gene lack the ability to repair damaged DNA by this repair process.

Dr Steve West, lead researcher, says: "This work helps us understand how the BRCA2 gene controls the processes that repair broken chromosomes. We now know that a specific region on the BRCA2 protein acts as a molecular switch to modify interactions with RAD51. This interaction controls the efficiency of RAD51-dependent DNA repair. So, BRCA2 proteins missing this region are unable to interact with RAD51 properly, and this can result in cancer predisposition."

Dr Lesley Walker, Director of Cancer Information at Cancer Research UK says: "This work shows how important the structure of the BRCA2 protein is in the DNA repair process. The interaction between RAD51 and the BRCA2 protein act as a 'pathfinder' to guide the RAD51 to the damaged areas of DNA. When a specific region is missing from the BRCA2 protein, it's a bit like having a car breakdown abroad, and a map and a mechanic available in the UK. You have the expertise and tools to fix the problem, but no way of getting there."
 

- Nature Volume 434 No 7033 pages 598 - 604.
 

Information on breast and ovarian cancer is available on Cancer Research UK's patient information website

 
Subscribe to Breast Newsletter
E-mail Address:

 

Researchers have found that a specific site on the BRCA2 protein, called S3291, gets modified by the addition of phosphate groups. This phosphorylation blocks interactions between BRCA2 and RAD51, impeding the repair mechanism. The extent of S3291 phosphorylation varies depending on the stage of the cell cycle. It is lowest when cells are replicating their DNA, so that BRCA2 and RAD51 can interact, and DNA damage that occurs at this time can be repaired.

Faults in the breast cancer genes BRCA1 and BRCA2 increase cancer risk because they are both genes that normally protect cells from cancerous changes. So a BRCA gene fault doesn't mean a person has cancer, or that they'll definitely get cancer. But it does mean that breast cancer is more likely because breast cells are one step further along the road than if you didn't have the gene fault.


Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us